ZNF24 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.866100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.250000E-01
Normal-vs-Stage2
3.668000E-02
Normal-vs-Stage3
1.024000E-01
Normal-vs-Stage4
4.938200E-01
Stage1-vs-Stage2
2.136400E-01
Stage1-vs-Stage3
3.683600E-02
Stage1-vs-Stage4
9.263800E-01
Stage2-vs-Stage3
9.32970000144806E-08
Stage2-vs-Stage4
2.446000E-01
Stage3-vs-Stage4
7.650500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.447700E-02
Normal-vs-AfricanAmerican
3.776000E-01
Normal-vs-Asian
6.157600E-03
Caucasian-vs-AfricanAmerican
3.129400E-01
Caucasian-vs-Asian
9.765700E-02
AfricanAmerican-vs-Asian
2.012400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.107800E-02
Normal-vs-Female
1.096230E-01
Male-vs-Female
3.431400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.781600E-01
Normal-vs-Age(41-60Yrs)
2.365200E-01
Normal-vs-Age(61-80Yrs)
3.336100E-02
Normal-vs-Age(81-100Yrs)
4.884000E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.584600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.314600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.578800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.238700E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.235700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.439600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.140690E-03
Normal-vs-Daily Drinker
5.956800E-03
Normal-vs-Weekly Drinker
1.411640E-02
Normal-vs-Occasional Drinker
3.920800E-01
Normal-vs-Social Drinker
5.309000E-01
Non Drinker-vs-Daily Drinker
9.481800E-01
Non Drinker-vs-Weekly Drinker
4.089400E-01
Non Drinker-vs-Occasional Drinker
2.202300E-02
Non Drinker-vs-Social Drinker
3.135600E-02
Daily Drinker-vs-Weekly Drinker
4.550400E-01
Daily Drinker-vs-Occasional Drinker
2.573800E-02
Daily Drinker-vs-Social Drinker
3.302400E-02
Weekly Drinker-vs-Occasional Drinker
8.589500E-02
Weekly Drinker-vs-Social Drinker
8.572200E-02
Occasional Drinker-vs-Social Drinker
7.983400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.188300E-02
Normal-vs-Grade 2
6.720300E-02
Normal-vs-Grade 3
3.783900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.247800E-02
Grade 1-vs-Grade 3
1.024150E-01
Grade 1-vs-Grade 4
9.188300E-02
Grade 2-vs-Grade 3
8.413800E-01
Grade 2-vs-Grade 4
6.720300E-02
Grade 3-vs-Grade 4
3.783900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.601100E-03
Normal-vs-NonDiabetic
5.897900E-02
Diabetic-vs-NonDiabetic
1.431800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.384390E-01
Normal-vs-NoPancreatitis
5.132100E-02
Pancreatitis-vs-NoPancreatitis
8.622100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.522000E-01
Normal-vs-N1
4.409900E-02
N0-vs-N1
8.559000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.440200E-02
Normal-vs-TP53-NonMutant
4.174200E-01
TP53-Mutant-vs-TP53-NonMutant
1.832880E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
